Hysterectomy: What Needs to be Removed?

Mary Jane Minkin

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

Recent FDA Indications in Endometrial Cancers

Brian Slomovitz

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

Endometrial Cancer: The Current Treatment Landscape

Hope Cottrill

ESMO 2024 Insights: Pembro or Placebo in Combination With Adjuvant C…

2024 ESMO Annual Meeting Insights Hub

B. Slomovitz

IGCS 2024 Summary and Highlights: Key Trial Insights on Endometrial …

UCLA Health

D. Chase

Advancing Precision: Innovations in Minimally Invasive Gynecologic S…

Jessica Opoku-Anane

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

The Changing Field of Endometrial Cancer Treatment

GRACE

M. Raza Mirza

SGO 2024 Endometrial Cancer Highlights

Insights from 2024 SGO Annual Meeting

P. Binder

Successful Carboplatin Desensitization Protocol in Gynecologic Cance…

Mariateresa Lapresa

Efficacy and Safety of Sacituzumab Govitecan in Advanced/Metastatic …

Alessandro Santin

Cancer Screening Molecular Tools

Fengting Yan

Durvalumab/C/T as 1L Treatment for dMMR Advanced Endometrial Cancer:…

Dana Chase

Precision Oncology in the Management of Endometrial Cancer

Miami Cancer Institute Precision Oncology Symposium

J. Diaz, B. Slomovitz

Phase III Trials of Adjuvant Radiotherapy and Chemotherapy in Endome…

GRACE

M. Raza Mirza